ArticleAntimicrobial agents and chemotherapy2014

Baseline hepatitis C virus (HCV) NS3 polymorphisms and their impact on treatment response in clinical studies of the HCV NS3 protease inhibitor faldaprevir.

Kristi L Berger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.